Compounds > levodopa
Page last updated: 2024-08-17

levodopa and Ataxias, Hereditary

levodopa has been researched along with Ataxias, Hereditary in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Cherian, A; K P, D; Krishnan, S; Vijayaraghavan, A1
Emmel, VE; Hilbig, A; Jardim, LB; Rieder, CR; Saraiva-Pereira, ML; Socal, MP1
Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H1
Muthane, U; Ragothaman, M1
Pulst, SM; Sutton, JP1
Chang, HC; Chen, RS; Liao, KK; Lu, CS; Tsai, CH1
Birnbaum, A; Blair, RD; Kierans, C; Lang, AE1

Other Studies

7 other study(ies) available for levodopa and Ataxias, Hereditary

ArticleYear
Pearls & Oy-sters: SCA21 Due to
    Neurology, 2022, Sep-20, Volume: 99, Issue:12

    Topics: alpha-Fetoproteins; Dystonia; Dystonic Disorders; Humans; Levodopa; Membrane Proteins; Myoclonus; Spinocerebellar Degenerations

2022
Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions.
    Parkinsonism & related disorders, 2009, Volume: 15, Issue:5

    Topics: Adult; Age of Onset; Antiparkinson Agents; Ataxin-3; Ataxins; DNA Repeat Expansion; Family; Female; Genes, Dominant; Genetic Variation; Humans; Levodopa; Machado-Joseph Disease; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Parkinson Disease; Pedigree; Phenotype; Repressor Proteins; Spinocerebellar Degenerations

2009
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
    The Tohoku journal of experimental medicine, 2006, Volume: 209, Issue:2

    Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome

2006
Homozygous SCA 2 mutations changes phenotype and hastens progression.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-15, Volume: 23, Issue:5

    Topics: Antiparkinson Agents; Ataxins; Dementia; Disease Progression; Dyskinesias; Female; Follow-Up Studies; Homozygote; Humans; Levodopa; Male; Mutation; Nerve Tissue Proteins; Ocular Motility Disorders; Parkinsonian Disorders; Phenotype; Psychotic Disorders; Spinocerebellar Degenerations

2008
Atypical parkinsonism in a family of Portuguese ancestry: absence of CAG repeat expansion in the MJD1 gene.
    Neurology, 1997, Volume: 48, Issue:5

    Topics: Adult; Base Sequence; Eye Diseases; Female; Genes; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Mutation; Parkinson Disease; Pedigree; Portugal; Repetitive Sequences, Nucleic Acid; Spinocerebellar Degenerations

1997
Acanthocytosis and spinocerebellar degeneration: a new association?
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:3

    Topics: Acanthocytes; Adult; Anticonvulsants; Antiparkinson Agents; Carbidopa; Cerebellum; Clonazepam; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Male; Spinocerebellar Degenerations; Videotape Recording; Vitamin E

1997
Levodopa dose-related fluctuations in presumed olivopontocerebellar atrophy.
    Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:2

    Topics: Aged; Brain; Female; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Spinocerebellar Degenerations; Tomography, X-Ray Computed

1986